Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Blood (2012) 120 (21): 964.

https://doi.org/10.1182/blood.V120.21.964.964

Published: 2012

Journal Articles

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

Willemijn Hobo, Kelly Broen, Walter J.F.M. van der Velden, MD, PhD, Annelies Greupink-Draaisma, Niken Adisty, Yannick Wouters, Michel G.D. Kester, Hanny Fredrix, Joop H. Jansen, PhD, Bert A. van der Reijden, PhD, J.H. Frederik Falkenburg, Theo de Witte, MD, PhD, Frank W.M.B. Preijers, PhD, Anton Schattenberg, MD, PhD, Ton Feuth, Nicole N.A. Blijlevens, MD, PhD, Nicolaas Schaap, MD, PhD, Harry Dolstra, PhD

Blood (2011) 118 (21): 4136.

https://doi.org/10.1182/blood.V118.21.4136.4136

Published: 2011

Journal Articles

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Eline Cremers, Anja van Biezen, StatAnalyst, Liesbeth C. de Wreede, PhD, Marijke Scholten, Antonin Vitek, Jürgen Finke, Uwe Platzbecker, MD, Dietrich Beelen, Rainer Schwerdtfeger, Liisa Volin, Nikolaos Harhalakis, Anton Schattenberg, Arnon Nagler, Theo de Witte, MD, PhD, Nicolaus Kröger

Blood (2011) 118 (21): 3014.

https://doi.org/10.1182/blood.V118.21.3014.3014

Published: 2011

Journal Articles

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Noortje Thielen, Bronno van der Holt, Jan J Cornelissen, MD PhD, Rianne Ammerlaan, Pieter Sonneveld, MD, PhD, Marie José Kersten, J.H. Frederik Falkenburg, Harm Sinnige, Martin Schipperus, Anton Schattenberg, Marinus van Marwijk Kooy, Willem Smit, Gregor Verhoef, Isabel Chu, Peter Valk, Jeroen JWM Janssen, MD PhD, Gert Ossenkoppele, MD, PhD

Blood (2011) 118 (21): 2758.

https://doi.org/10.1182/blood.V118.21.2758.2758

Published: 2011

Journal Articles

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Blood (2010) 116 (21): 688.

https://doi.org/10.1182/blood.V116.21.688.688

Published: 2010

Journal Articles

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Irit Avivi, MD, Carmen Canals, Jian Jian Luan, Gerald. G. Wulf, Arnon Nagler, M.D., Agnes Buyzin, Eefke J. Petersen, MD, PhD, Jean-Pierre Jouet, MD, Donald Milligan, MD, FRCP, FRCPath, Anton Schattenberg, MD, Dietger W Niederwieser, MD, Kirsty Thomson, Didier Blaise, MD, Michel Attal, Gerhard Held, MD, Peter Dreger, MD, PhD, Anna Sureda, MD, PhD

Blood (2010) 116 (21): 363.

https://doi.org/10.1182/blood.V116.21.363.363

Published: 2010

Journal Articles

Poor-Risk Acute Leukemia Patients with An EBMT Low-Risk Score and An 8/8 Matched Unrelated Donor Show Excellent Survival After Hematopoietic Stem Cell Transplantation.

Tom Lodewyck, MD, Machteld Oudshoorn, PhD, Bronno van der Holt, PhD, Eefke Petersen, MD, PhD, Eric Spierings, PhD, Peter A. Von Dem Borne, MD, PhD, Anton Schattenberg, MD, PhD, Wil Allebes, PhD, Ellen Meijer, MD, PhD, Marlies Groenendijk-Sijnke, Lucia Duinhouwer, Roelof Willemze, MD, PhD, Leo F. Verdonck, MD, PhD, Bob Lowenberg, MD, PhD, Jan J. Cornelissen, MD, PhD

Blood (2009) 114 (22): 1196.

https://doi.org/10.1182/blood.V114.22.1196.1196

Published: 2009

Journal Articles

Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT.

Grzegorz Wladyslaw Basak, Anja van Biezen, Ronald Brand, Christoph Schmid, Cesare Guglielmi, Anton Schattenberg, Richard Szydlo, Peter A. Von Dem Borne, Leo Verdonck, Donald W. Bunjes, Wieslaw Wiktor-Jedrzejczak, Eduardo Olavarria, Theo de Witte

Blood (2009) 114 (22): 3309.

https://doi.org/10.1182/blood.V114.22.3309.3309

Published: 2009

Journal Articles

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

Alois Gratwohl, Ronald Brand, Jane Apperley, Anja v. Biezen, Giuseppe Bandini, Agnes Devergie, Anton Schattenberg, Francesco Frassoni, Cesare Guglielmi, Simona Iacobelli, Mauricette Michallet, Hans-Jochen Kolb, Tapani Ruutu, Dietger Niederwieser

Blood (2002) 100 (12): 3877–3886.

https://doi.org/10.1182/blood.V100.12.3877

Published: 2002

Journal Articles

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)

Loı̈c Fouillard, Myriam Labopin, Norbert-Claude Gorin, Emmanuelle Polge, Hugh Grant Prentice, Giovanna Meloni, Josy Reiffers, Arnaud Pigneux, Roel Willemze, Anton Schattenberg, Simona Sica, Monique Lagrange, Odile Fenneteau, Christine Perot, Francesco Frassoni

Blood (2002) 100 (9): 3135–3140.

https://doi.org/10.1182/blood.V100.9.3135

Published: 2002

Journal Articles

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Cesare Guglielmi, William Arcese, Francesco Dazzi, Ronald Brand, Donald Bunjes, Leo F. Verdonck, Anton Schattenberg, Hans-Jochem Kolb, Per Ljungman, Agnes Devergie, Andrea Bacigalupo, Marta Gomez, Mauricette Michallet, Ahmet Elmaagacli, Alois Gratwohl, Jane Apperley, Dietger Niederwieser

Blood (2002) 100 (2): 397–405.

https://doi.org/10.1182/blood.V100.2.397

Published: 2002

NARROW

Autologous Hematopoietic Stem Cell Transplantation Versus Intravenous Pulse Therapy Cyclophosphamide for Severe or Rapidly Progressive Systemic Sclerosis, the Astis Trial

Association of Disparities in Known Minor Histocompatibility Antigens with Relapse-Free Survival and Graft-Versus-Host-Disease Upon Allogeneic Stem Cell Transplantation,

Prognostic Pre-Transplant Factors in Myelodysplastic Syndromes Primarily Treated by Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Study on Behalf of the MDS Subcommittee of the Chronic Leukaemia Working Party of the EBMT

Preliminary Results From a Phase III Trial of Imatinib Versus Imatinib in Combination with Cytarabine in Patients with First Chronic Phase Myeloid Leukemia

Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT

Matched Unrelated Donor Transplantation Is Curative In Selected Patients with Diffuse Large B Cell Lymphoma: A Report of the Lymphoma Working Party (LWP) of the European Group for Blood and Marrow Transplantation (EBMT)

Poor-Risk Acute Leukemia Patients with An EBMT Low-Risk Score and An 8/8 Matched Unrelated Donor Show Excellent Survival After Hematopoietic Stem Cell Transplantation.

Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT.

Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia

Hematopoietic stem cell transplantation for de novo erythroleukemia: a study of the European Group for Blood and Marrow Transplantation (EBMT)

Donor lymphocyte infusion for relapsed chronic myelogenous leukemia: prognostic relevance of the initial cell dose

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only